Corrigendum to "Clinical relevance of gene mutations and rearrangements in advanced differentiated thyroid cancer": [ESMO Open 8 (2023) 102039].

Autor: Nannini M; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna. Electronic address: margherita.nannini@unibo.it., Repaci A; Division of Endocrinology and Diabetes Prevention and Care, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna., Nigro MC; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna., Colapinto A; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna., Vicennati V; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna; Division of Endocrinology and Diabetes Prevention and Care, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna., Maloberti T; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna., Gruppioni E; Solid Tumor Molecular Pathology Laboratory, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna., Altimari A; Solid Tumor Molecular Pathology Laboratory, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna., Solaroli E; Endocrinology Unit-Azienda USL di Bologna, Bologna., Lodi Rizzini E; Division of Radiation Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Sant'Orsola-Malpighi Hospital, Bologna., Monari F; Division of Radiation Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Sant'Orsola-Malpighi Hospital, Bologna., De Leo A; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna., Damiani S; Pathology Unit, Department of Pathology, Bellaria & Maggiore Hospital, AUSL di Bologna, Bologna., Pagotto U; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna; Division of Endocrinology and Diabetes Prevention and Care, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna., Pantaleo MA; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna., de Biase D; Solid Tumor Molecular Pathology Laboratory, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna; Department of Pharmacy and Biotechnology (FaBiT), University of Bologna, Bologna, Italy., Tallini G; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna; Solid Tumor Molecular Pathology Laboratory, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna.

Publikováno v: ESMO open [ESMO Open] 2024 Nov; Vol. 9 (11), pp. 103704. Date of Electronic Publication: 2024 Oct 18.

Direct detection of antihydrogen atoms using a BGO crystal

Autor: Nagata, Y., Kuroda, N., Ohtsuka, M., Leali, M., Lodi-Rizzini, E., Mascagna, V., Tajima, M., Torii, H.A., Zurlo, N., Matsuda, Y., Venturelli, L., Yamazaki, Y.

Publikováno v: In Nuclear Inst. and Methods in Physics Research, A 21 December 2016 840:153-159

Thorotrast: Analysis of the time evolution of its α activity concentration, in the 70 years following the chemical purification of Thorium

Autor: Bianconi, A., Corradini, M., Leali, M., Lodi Rizzini, E., Venturelli, L., Zurlo, N.

Publikováno v: In Physica Medica September 2013 29(5):520-530

Antiproton-nucleus annihilation cross section at low energy

Autor: Aghai–Khozani H., Bianconi A., Corradini M., Hayano R., Hori M., Leali M., Lodi–Rizzini E., Mascagna V., Murakami Y., Prest M., Vallazza E., Venturelli L., Yamada H.

Publikováno v: EPJ Web of Conferences, Vol 182, p 03013 (2018)

The antinucleon-nuclei annihilation cross sections at low energies were systematically measured at CERN in the 80’s and 90’s with the LEAR facility and later with the Antiproton Decelerator. Unfortunately only few data exist for very low energy a

Externí odkaz: https://doaj.org/article/a09c260d004741d599606c5fe690b92d

B21 - 223Ra-chloride therapy: the first multidisciplinary and multicenter Italian study

Autor: Farnesi, A., Mazzarri, S., Boni, G., Galli, L., Cianci, C., Biasco, E., Sbrana, A., Paolieri, F., Bloise, F., Ghedini, P., Lodi Rizzini, E., Dionisi, V., Borsatti, E., Bortolus, R., Fratino, L., Gobitti, C., Fanti, S., Volterrani, D., Monari, F., Ricci, S., Falcone, A.

Publikováno v: In Annals of Oncology October 2017 28 Supplement 6:vi23-vi23